Tumour evolution was first identified 40 years ago. We’re finally making good progress with it.
Articles on Prostate cancer
Displaying 61 - 80 of 98 articles
Getting the right amount of radiation is a fine balance between therapy and harm. A common way to improve the benefit-to-cure ratio is to fire multiple beams at the tumour from different directions.
With changes to health care insurance on hold, now may be a good time to focus not on health insurance but on health. More and more studies show that we do have some control over that. Here’s how.
Obesity is linked with a host of health outcomes. Both a disease itself and a risk factor linked to many others, we explore the linkages between obesity and cancer.
Hold up: mindfulness training as a complementary therapy in cancer treatment might not work for everyone.
What started with a study of diseases transmitted by mosquitos, could end with a new way of treating cancer.
Currently, seven cancer types are listed in the top 20 causes of death in Australia. These are cancers of the lung, blood and lymph, bowel, prostate, breast, pancreas, skin and some childhood cancers.
The cost of cancer drugs is killing patients and it needs to stop
In news which may come as a relief to apprehensive men and short-fingered doctors alike, guidelines are now changing.
Screening for prostate cancer using the prostate specific antigen (PSA) test for men with no symptoms is controversial: experts are divided, and Australians are not routinely well-informed. Prostate cancer…
Across 38 years in tobacco control, I have been asked countless times in media interviews if I ever smoked. It’s often an early question. I always unhesitatingly explain that I did: I stopped in my mid…
“It might do me some good and it won’t hurt to give it a go.” How often have you heard a phrase like this? Most people have naïve optimism about medical care. That’s the finding of a systematic review…
Cancer Council Australia and the Prostate Cancer Foundation of Australia yesterday released new draft guidelines to help GPs counsel men who ask about prostate cancer tests. They advise GPs to explain…
Healthy men aged 50 to 69 years who request a prostate cancer check will be offered a blood test every two years if draft guidelines released today by two peak cancer groups are adopted. The guidelines…
Ovarian cancer is the fifth highest killer in women when it comes to cancer, according to statistics from the American Cancer Society, with about 14,000 deaths in the United States alone this year. The…
More and more people are beating cancer – over the past 20 years the proportion of people surviving the disease for more than ten years has increased by a third, from 34% to 45%. But as the population…
Prostate cancer is the most commonly diagnosed cancer in Australia with 25,000 new cases expected in 2020. But mortality…
The Movember campaign, which encourages men to grow moustaches each November to raise funds and awareness for men’s health, has helped raise the profile of prostate cancer. Statistics such as “one in eight…
If you or someone close to you has lived with prostate cancer, you’ve probably come across dozens of emerging treatments in your hours of Googling. One such treatment, focal therapy, has been dubbed the…
A report published in the Journal of the National Cancer Institute late last week shows a potential link between omega-3 fatty acids and the risk of developing prostate cancer. But it may be premature…
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Head of Urology at Monash Medical Centre and Associate Professor of Surgery, Monash University
-
Professor of Medicine, Bond University
-
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Emeritus Professor in Public Health, University of Sydney
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Senior Research Officer, Blood Cells and Blood Cancer, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
NHMRC Emerging Leader Research Fellow, School of Public Health, University of Sydney
-
Senior Lecturer in Biochemistry, Sheffield Hallam University
-
Research Fellow, Prostate Cancer Research Group, Monash University
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Senior Research Officer, Blood Cells and Blood Cancer Division, WEHI (Walter and Eliza Hall Institute of Medical Research)
-
Senior Associate Vice President Community Health, Education and Training, Old Dominion University; Associate Professor of Pharmacy, University of Florida
-
Professor of Clinical Epidemiology, Bond University
-
Senior Lecturer in Chemical Pathology, University of Westminster